Molecular Endocrinology, Vol 6, 805-814, Copyright © 1992 by Endocrine Society

ARTICLES

The unique C-termini of the thyroid hormone receptor variant, c-erbA alpha 2, and thyroid hormone receptor alpha 1 mediate different DNA- binding and heterodimerization properties

D Katz, TJ Berrodin and MA Lazar
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

Thyroid hormone receptors (TRs) mediate the regulation of gene transcription by thyroid hormone (T3) by binding to T3-responsive elements (TREs) in target genes. c-erbA alpha 2 is a C-terminal TR variant which does not bind T3 and is a dominant inhibitor of T3 action. When synthesized in Escherichia Coli, alpha 2 formed two TRE- binding complexes similar to the monomeric and homodimeric forms of TR alpha 1. However, alpha 2 did not bind nearly as well as TR alpha 1. Furthermore, alpha 2 failed to bind DNA with proteins that heterodimerized with TR alpha 1. TR alpha 1 and alpha 2 also did not bind DNA as heterodimers with one another. The differences between TR alpha 1 and alpha 2 were further analyzed by studying a variety of C- terminal mutants synthesized in reticulocyte lysates. Deletion of the last 20 of the 122 unique amino acids (aa) of alpha 2 increased its DNA binding to approximately the level of TR alpha 1, indicating that the C- terminus of alpha 2 is an inhibitory domain. This alpha 2 mutant (alpha 2 delta C) was still unable to heterodimerize with nuclear proteins, as were C-terminal deletion mutants of TR alpha 1. We hypothesized that fusion of TR alpha 1-specific sequences to the C-terminus of alpha 2 delta C would transfer the property of heterodimerization. Indeed, although alpha 2/alpha 1 chimeras containing the last 40 and 70 aa of TR alpha 1 failed to heterodimerize with nuclear proteins, addition of the last 100 or 150 aa of TR alpha 1 did render alpha 2 delta C heterodimerization competent. Thus, TR alpha 1 contains a C-terminal structure which is necessary for heterodimerization and can confer this property on alpha 2, which lacks this domain. The effects of the unique C-termini of TR alpha 1 and alpha 2 on their in vitro DNA binding have important implications for their mechanisms of action in vivo.

This article has been cited by other articles:

				E. R. Nelson and H. R. Habibi Functional Significance of a Truncated Thyroid Receptor Subtype Lacking a Hormone-Binding Domain in Goldfish Endocrinology, September 1, 2008; 149(9): 4702 - 4709. [Abstract] [Full Text] [PDF]

				C R Liu, L Y Li, F Shi, X Y Zang, Y M Liu, Y Sun, and B H Kan Effects of hyper- and hypothyroid on expression of thyroid hormone receptor mRNA in rat myocardium J. Endocrinol., December 1, 2007; 195(3): 429 - 438. [Abstract] [Full Text] [PDF]

				C. Salto, J. M. Kindblom, C. Johansson, Z. Wang, H. Gullberg, K. Nordstrom, A. Mansen, C. Ohlsson, P. Thoren, D. Forrest, et al. Ablation of TR{alpha}2 and a Concomitant Overexpression of {alpha}1 Yields a Mixed Hypo- and Hyperthyroid Phenotype in Mice Mol. Endocrinol., December 1, 2001; 15(12): 2115 - 2128. [Abstract] [Full Text] [PDF]

				M. L. Hastings, H. A. Ingle, M. A. Lazar, and S. H. Munroe Post-transcriptional Regulation of Thyroid Hormone Receptor Expression by cis-Acting Sequences and a Naturally Occurring Antisense RNA J. Biol. Chem., April 6, 2000; 275(15): 11507 - 11513. [Abstract] [Full Text] [PDF]

				G. B. Atkins, X. Hu, M. G. Guenther, C. Rachez, L. P. Freedman, and M. A. Lazar Coactivators for the Orphan Nuclear Receptor ROR{alpha} Mol. Endocrinol., September 1, 1999; 13(9): 1550 - 1557. [Abstract] [Full Text]

				T. Tagami, P. Kopp, W. Johnson, O. K. Arseven, and J. L. Jameson The Thyroid Hormone Receptor Variant {alpha}2 Is a Weak Antagonist because It Is Deficient in Interactions with Nuclear Receptor Corepressors Endocrinology, May 1, 1998; 139(5): 2535 - 2544. [Abstract] [Full Text] [PDF]

				A. Farsetti, J. Lazar, M. Phyillaier, R. Lippoldt, A. Pontecorvi, and V. M. Nikodem Active Repression by Thyroid Hormone Receptor Splicing Variant {alpha}2 Requires Specific Regulatory Elements in the Context of Native Triiodothyronine-Regulated Gene Promoters Endocrinology, November 1, 1997; 138(11): 4705 - 4712. [Abstract] [Full Text] [PDF]

				M. J. Reginato, J. Zhang, and M. A. Lazar DNA-independent and DNA-dependent Mechanisms Regulate the Differential Heterodimerization of the Isoforms of the Thyroid Hormone Receptor with Retinoid X Receptor J. Biol. Chem., November 8, 1996; 271(45): 28199 - 28205. [Abstract] [Full Text] [PDF]

				Y.-Z. Yang, M. Burgos-Trinidad, Y. Wu, and R. J. Koenig Thyroid Hormone Receptor Variant alpha 2. ROLE OF THE NINTH HEPTAD IN DNA BINDING, HETERODIMERIZATION WITH RETINOID X RECEPTORS, AND DOMINANT NEGATIVE ACTIVITY J. Biol. Chem., November 8, 1996; 271(45): 28235 - 28242. [Abstract] [Full Text] [PDF]